United States Biotechnology & Medical Research

Zosano Pharma Corp (ZSAN)

Track

Ticker: ZSAN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Zosano Pharma Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 6 Jun 2022
Value US$3,915,890.95 | Price 432.88 | Shares 60,795 (-26.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-06-07 2022-06-06 S Sale
1.5
Lo Steven

Chief Executive Officer

Executive Director
60,795 -26.6%
432.88
US$3,915,891 		60,795 -26.6% 432.88 US$3,915,891
2022-06-07 2022-06-06 S Sale
Matthews Christine

Chief Financial Officer

Officer
57,363 +6.4%
365.37
US$4,755,801 		57,363 +6.4% 365.37 US$4,755,801
2022-04-01 2022-03-31 S Sale
KELLERMAN DONALD J

VP, Clinical Dev & Med Affairs

Officer
70,388 +35.2%
397.09
US$379,738 		70,388 +35.2% 397.09 US$379,738
2022-04-01 2022-03-31 S Sale
Matthews Christine

Chief Financial Officer

Officer
8,116 -5.3%
0.21
US$1,705 		8,116 -5.3% 0.21 US$1,705
2022-04-01 2022-03-31 S Sale
1.5
Lo Steven

Chief Executive Officer

Executive Director
23,633 -4.9%
0.21
US$4,965 		23,633 -4.9% 0.21 US$4,965
2021-11-24 2021-11-23 S Sale
3.3
GREATHOUSE KENNETH
Non-Executive Director
10,000 -18.7%
0.60
US$6,018 		10,000 -18.7% 0.60 US$6,018
2021-06-07 2021-06-04 S Sale
Lewis Hayley

See Remarks

Officer
1,709 -3.3%
0.81
US$1,376 		1,709 -3.3% 0.81 US$1,376
2021-06-07 2021-06-04 S Sale
KELLERMAN DONALD J

VP, Clinical Dev & Med Affairs

Officer
1,709 -3.3%
0.81
US$1,376 		1,709 -3.3% 0.81 US$1,376
2021-06-07 2021-06-04 S Sale
Matthews Christine

Chief Financial Officer

Officer
1,709 -1.7%
0.81
US$1,376 		1,709 -1.7% 0.81 US$1,376
2019-04-18 2019-04-11 B Purchase
0.8
WALKER JOHN PETER

President & CEO

Executive Director
100,000 +55.5%
3.50
US$350,000 		100,000 +55.5% 3.50 US$350,000
2018-02-28 2018-02-27 S Sale Amzak Capital Management, LLC Large shareholder
5,901 -100.0%
8.26
US$48,760 		5,901 -100.0% 8.26 US$48,760
2018-02-28 2018-02-27 S Sale Amzak Capital Management, LLC Large shareholder
80,880 -31.6%
8.36
US$675,914 		80,880 -31.6% 8.36 US$675,914
2018-02-28 2018-02-26 S Sale Amzak Capital Management, LLC Large shareholder
1,500 -0.6%
11.00
US$16,500 		1,500 -0.6% 11.00 US$16,500
2017-12-08 2017-12-06 B Purchase GREATHOUSE KENNETH
55,000 +37.9%
0.61
US$33,407 		55,000 +37.9% 0.61 US$33,407
2017-12-04 2017-12-01 B Purchase GREATHOUSE KENNETH
50,000 +52.6%
0.62
US$31,080 		50,000 +52.6% 0.62 US$31,080
2017-12-04 2017-11-30 B Purchase GREATHOUSE KENNETH
45,000 +90.0%
0.62
US$27,927 		45,000 +90.0% 0.62 US$27,927
2017-11-16 2017-11-15 B Purchase GREATHOUSE KENNETH
15,000 +42.9%
0.58
US$8,674 		15,000 +42.9% 0.58 US$8,674
2017-11-16 2017-11-14 B Purchase GREATHOUSE KENNETH
35,000 +inf%
0.64
US$22,484 		35,000 +inf% 0.64 US$22,484
2017-05-25 2017-05-25 B Purchase Erbez Georgia

CFO and Chief Business Officer

Officer
68,000 +142.4%
1.32
US$89,760 		68,000 +142.4% 1.32 US$89,760
2017-05-25 2017-05-25 B Purchase WALKER JOHN PETER

Interim CEO

Executive Director
37,550 +22.2%
1.37
US$51,338 		37,550 +22.2% 1.37 US$51,338
2017-05-25 2017-05-24 B Purchase WALKER JOHN PETER

Interim CEO

Executive Director
36,166 +27.2%
1.34
US$48,553 		36,166 +27.2% 1.34 US$48,553
2017-02-14 2017-02-13 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
1,099,996 -53.6%
2.01
US$2,211,432 		1,099,996 -53.6% 2.01 US$2,211,432
2017-02-14 2017-02-13 S Sale BARRETT M JAMES Large shareholder
1,099,996 -53.6%
2.01
US$2,211,432 		1,099,996 -53.6% 2.01 US$2,211,432
2016-09-20 2016-09-16 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
7,471 -0.4%
0.75
US$5,603 		7,471 -0.4% 0.75 US$5,603
2016-09-20 2016-09-16 S Sale BARRETT M JAMES Large shareholder
7,471 -0.4%
0.75
US$5,603 		7,471 -0.4% 0.75 US$5,603
2016-09-15 2016-09-13 S Sale BARRETT M JAMES Large shareholder
10,000 -0.5%
0.74
US$7,400 		10,000 -0.5% 0.74 US$7,400
2016-09-15 2016-09-13 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
10,000 -0.5%
0.74
US$7,400 		10,000 -0.5% 0.74 US$7,400
2016-08-31 2016-08-29 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
50,000 -2.4%
1.01
US$50,440 		50,000 -2.4% 1.01 US$50,440
2016-08-31 2016-08-29 S Sale BARRETT M JAMES Large shareholder
50,000 -2.4%
1.01
US$50,440 		50,000 -2.4% 1.01 US$50,440
2016-08-26 2016-08-24 S Sale BARRETT M JAMES Large shareholder
1,200 -0.1%
1.21
US$1,452 		1,200 -0.1% 1.21 US$1,452
2016-08-26 2016-08-24 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
1,200 -0.1%
1.21
US$1,452 		1,200 -0.1% 1.21 US$1,452
2016-08-22 2016-08-19 B Purchase Erbez Georgia

Interim CFO

Officer
47,750 +inf%
1.32
US$63,030 		47,750 +inf% 1.32 US$63,030
2016-08-22 2016-08-19 B Purchase KELLERMAN DONALD J

VP, Clinical Dev & Med Affairs

Officer
15,920 +inf%
1.32
US$21,014 		15,920 +inf% 1.32 US$21,014
2016-08-22 2016-08-19 B Purchase Lewis Hayley

VP, Reg Affairs & Quality

Officer
4,775 +inf%
1.32
US$6,303 		4,775 +inf% 1.32 US$6,303
2016-08-22 2016-08-19 B Purchase WALKER JOHN PETER Non-Executive Director
63,700 +inf%
1.32
US$84,084 		63,700 +inf% 1.32 US$84,084
2016-08-22 2016-08-19 B Purchase Alataris Konstantinos

President, CEO

Executive Director
127,389 +inf%
1.32
US$168,153 		127,389 +inf% 1.32 US$168,153
2016-08-22 2016-08-19 B Purchase XANTHOPOULOS KLEANTHIS G Non-Executive Director
15,920 +265.3%
1.32
US$21,014 		15,920 +265.3% 1.32 US$21,014
2016-07-21 2016-07-21 S Sale BARRETT M JAMES Large shareholder
8,989 -0.4%
1.33
US$11,957 		8,989 -0.4% 1.33 US$11,957
2016-07-21 2016-07-21 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
8,989 -0.4%
1.33
US$11,957 		8,989 -0.4% 1.33 US$11,957
2016-07-21 2016-07-20 S Sale BARRETT M JAMES Large shareholder
14,158 -0.7%
1.24
US$17,550 		14,158 -0.7% 1.24 US$17,550
2016-07-21 2016-07-20 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
14,158 -0.7%
1.24
US$17,550 		14,158 -0.7% 1.24 US$17,550
2016-07-21 2016-07-19 S Sale BARRETT M JAMES Large shareholder
534 -0.0%
1.17
US$625 		534 -0.0% 1.17 US$625
2016-07-21 2016-07-19 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
534 -0.0%
1.17
US$625 		534 -0.0% 1.17 US$625
2016-07-15 2016-07-13 S Sale BARRETT M JAMES Large shareholder
13,382 -0.6%
1.20
US$16,060 		13,382 -0.6% 1.20 US$16,060
2016-07-15 2016-07-13 S Sale New Enterprise Associates 12, Limited Partnership Large shareholder
13,382 -0.6%
1.20
US$16,060 		13,382 -0.6% 1.20 US$16,060
2015-02-02 2015-01-30 B Purchase BARRETT M JAMES Non-Executive Director Large shareholder
23,457 +1.1%
11.00
US$258,027 		23,457 +1.1% 11.00 US$258,027
2015-02-02 2015-01-30 B Purchase New Enterprise Associates 12, Limited Partnership Large shareholder
23,457 +1.1%
11.00
US$258,027 		23,457 +1.1% 11.00 US$258,027
2015-02-02 2015-01-30 B Purchase BioMed Realty Trust Inc Large shareholder
26,543 +5.1%
11.00
US$291,973 		26,543 +5.1% 11.00 US$291,973
Explore more

More insider trading research around Zosano Pharma Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America